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The era of genomics (the study of genes and
their function) began a scant dozen years ago
with a suggestion by James Watson that the
complete DNA sequence of the human genome be
determined. Since that time, the human genome
project has attracted a great deal of attention in
the scientific world and the general media; the
scope of the sequencing effort, and the
extraordinary value that it will provide, has
served to mask the enormous progress in
sequencing other genomes. Microbial genome
sequencing, of particular interest to the
community studying emerging infectious dis-
eases, prompted the series of articles presented
in the following pages. These articles review
technological and scientific advances that have
occurred since publication of the Haemophilus
influenzae genome sequence in July 1995 (1); that
was the first demonstration that an entire
genome sequence could be deciphered by a
“shotgun” approach, i.e., the sequencing and
assembly of random fragments of the genome.
This is now the method of choice for sequencing of
most other genomes, including human (as
performed by Celera Genomics).
The articles by Fraser et al. (this issue,  pp.
505-12) and by Weinstock (pp. 496-504) briefly
describe some of the sequencing methods and
annotation of the completed sequences. As of this
writing (late June 2000), 23 bacterial genomes
have been fully sequenced. More than 70 other
microbial genome projects are under way; a
regularly updated listing is available on the
Internet (http://www.tigr.org/tdb/mdb/mdbin
progress.html). For some species, several strains
have been examined, facilitating whole genome
comparisons that provide insights not available
by other methods (Fraser et al., this issue).
Generally, the first analysis of a completed,
fully assembled genome consists of determining
all the putative open reading frames (ORFs),
which may constitute protein coding regions.
These derived amino acid sequences are searched
against sequence databases to determine the
relationship to previously sequenced genes.
There can be three results: a “hit” to a gene of
known function, a hit to a gene of unknown
function (usually referred to as a conserved
hypothetical protein), or no database match. In
the first instance,  the newly sequenced gene is
generally annotated as a homolog of the best hit.
When the first bacterial genome sequences were
elucidated, it was not surprising that a
significant percentage (35%-45%) of identified
ORFs either were of unknown function or had
no database match. More surprising is that
these numbers have not changed substantially
as more and more sequences have been
determined. Thus, close to half of all bacterial
ORFs identified to date have no known function,
half of which again are unique to the given
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species. This represents an enormous storehouse
of unrecognized metabolic potential, and it
appears obvious that many novel biochemical
reactions and pathways are yet to be discovered
and characterized. A recent example along these
lines is the construction of 6,144 individual yeast
strains, each containing an expression clone of all
identified yeast ORFs. This strain collection was
used for high throughput identification of three
previously unrecognized enzymatic activities (2).
Similar approaches should provide fertile ground
for many future biochemical investigations.
Homology searching and ORF identification
have been especially useful in revealing the
overall metabolic capability of an organism,
identifying potential targets for antimicrobial
therapy, and elucidating candidate virulence
genes. This information also provides a frame-
work for comparative studies of closely related
bacterial species and different strains (e.g.,
virulent and avirulent) of the same species.
Examples of each  are provided in the ensuing
articles by Fraser et al. and by Weinstock.
Despite the obvious value of such analyses,
however, some caution must be exercised.
Ultimately, the caliber of the bioinformatics tools
employed for sequence homology analysis and
ORF annotation determines the quality of the
data. Unquestionably, errors in annotation exist,
and these can result in erroneous classification of
newly identified genes. Often, annotated genes
are arranged into commonly identified metabolic
pathways, and certain key activities are
“missing.” This may suggest that the organism
under study may only contain a portion of the
particular pathway. However, given the large
reservoir of genes with unknown function, it is
equally plausible that another protein has
evolved to catalyze the missing reaction. This
process has been referred to as non-orthologous
gene displacement (3). How common such gene
displacement is will only become clear through
biochemical studies of the type described above.
Complete bacterial genome sequencing has
revealed more extensive genetic exchange between
species than suspected. Lateral or horizontal
gene transfer has been inferred from differences
in guanine-cytosine content or codon preference
in specific regions of a genome relative to the
entire genome. The best known examples of such
lateral exchange are the acquisition of antibiotic
resistance genes and pathogenicity islands. The
extent of lateral transfer has a profound impact
on the inference of phylogenetic relationships by
use of specific protein sequences and is the
subject of substantial debate (4-6). Fraser et al.
touch on these issues and present an approach to
phylogeny based on comparative genomics.
Perhaps the greatest value of complete
genome sequence information is its use in
generating hypotheses that can be further tested
by biological (“wet”) experiments. Weinstock
describes how complete genome sequences may
be scrutinized for clues to pathogenic mecha-
nisms and emphasizes that this is merely a
starting point for subsequent studies. In many
cases, putative virulence determinants can be
identified by homology to previously character-
ized proteins. This approach works reasonably
well for pathogens closely related to those that
have been extensively studied. However, for
many organisms (e.g, the spirochetes Borrelia
burgdorferi and Treponema pallidum), the
sequence provides markedly less insight into
potential pathogenic processes (7,8). Ultimately,
definitive demonstration that any candidate
virulence factor plays a role in pathogenesis is
best accomplished by genetic manipulation. For
example, disruption of a candidate gene should
abolish the ability of the mutated pathogen to
elicit disease in an animal model of infection, and
reintroduction of the wild-type gene should re-
establish virulence. For many pathogens, such
genetic tools are not yet available, but one hopes
that the genetics will soon catch up to the genomics.
One of the most exciting outcomes of the
genomics revolution is the ability to probe an
organism’s global gene expression under a
specified set of physiologic conditions. Variously
referred to as transcription or gene expression
profiling or monitoring, this technology is
facilitated by highly parallel analysis of mRNA
content in a cell using oligonucleotide chips or
cDNA microarrays. The review by Cummings
and Relman (this issue, pp. 513-25) describes
some technical aspects of the technology and its
specific application for the study of host-
pathogen interactions. Since the technique is not
truly quantitative, it is usually applied to
measuring the differences in expression of “all
the genes” in the organism under two different
growth conditions—for example, environmental
(changes in pH or temperature) or nutritional
(rich vs. minimal media). The genes that are
differentially expressed are assumed to be
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under these differing conditions. For eukaryotes,
this can also be used to uncover differences
between normal and diseased cells or tissues. A
particularly interesting extension of this ap-
proach is the study of alterations in host gene
expression on exposure to, or infection with, a
bacterial pathogen; this is discussed extensively
by Cummings and Relman. Like all enabling
technologies,  DNA microarray analysis has
manifold applications, and new ones will surely
be developed. In the context of bacterial
genomics, two additional uses are worthy of note.
As already described, close to half of annotated
ORFs have no known function, and some
percentage of these may not be genes at all.
Microarray analysis can elucidate the true
nature of the “expressed genome” by confirming
the expression of genes of unknown function. Of
course, as with all experimental data, a positive
result is meaningful, but a negative result must
be interpreted with caution since a particular
“gene” may be expressed only under a very
selective set of conditions (perhaps one not
amenable to facile experimental analysis).
Microarrays can also be employed in high-
throughput detection or diagnostic applications
based on ribosomal RNA hybridization (9,10).
This series of review articles on genomics,
like any other series covering a broad and rapidly
evolving area of investigation, cannot provide
comprehensive coverage of all topics. For
example, information on the development of
novel antimicrobial drugs and vaccines based on
whole genome sequencing data  (11-13) has not
been included. Finally, much of the early emphasis
in genomics has been on accumulating and
annotating raw sequence data. While certain
fundamental insights have been gained from
these data (e.g., the extent of lateral gene
exchange and existence of novel genes), ultimately,
the most profound advances will result from
using sequence information to drive the study of
microbial biology, i.e., how the genome deter-
mines function. Expression profiling is the first
step along this path. However, this technique
measures mRNA, the “message,” rather than the
protein gene product. Proteomics—describing the
complete protein complement of an organism—
has thus developed as the adjunct to genomics.
Proteomics has been made feasible by major
advances in high throughput mass spectrometry,
despite the fact that the core component of
the  technology remains two-dimensional gel
electrophoresis. Descriptions of the technique and
an example of its application to a microbial system
can be found in recent publications (14-16).
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